Skip to main content
. 2018 Mar 26;13:1037–1052. doi: 10.2147/COPD.S147262

Table S4.

Comparison of parameters between groups according to valid data (n=725)

Tested parameter Without 6-MWT and ABG (n=133) Only with 6-MWT (n=201) Only with ABG (n=40) With 6-MWT and ABG (n=351) p-value
Demography
Sex – men 97 (72.9%) 146 (72.6%) 25 (62.5%) 252 (71.8%) 0.597
Age at inclusion 67.4 (10.3) 65.3 (10.0) 69.4 (9.3) 67.0 (8.5) 0.078
BMI 26.7 (5.6) 27.1 (5.4) 25.9 (4.7) 26.9 (6.1) 0.553
Symptoms
mMRC 2.0 (1.1) 2.3 (0.9) 2.5 (1.1) 2.2 (1.2) 0.007
CAT 17.3 (8.2) 15.5 (7.2) 17.5 (8.0) 15.5 (7.9) 0.067
Exacerbations
Treated at home (moderate) 0.6 (1.1) 0.8 (1.2) 0.9 (1.1) 0.9 (1.5) 0.223
Requiring hospitalization (severe) 0.2 (0.6) 0.2 (0.5) 0.7 (0.8) 0.5 (0.9) <0.001
Total 0.8 (1.4) 1.0 (1.4) 1.6 (1.4) 1.4 (1.9) <0.001
Lung function
FEV1 (%) 45.3 (11.2) 47.7 (11.6) 44.8 (12.9) 43.2 (11.4) <0.001
FVC (%) 71.8 (16.8) 69.1 (15.2) 71.3 (15.5) 68.0 (19.5) 0.057
TLCO (% pred) 52.1 (21.9) 62.1 (24.1) 48.6 (16.2) 49.4 (21.0) <0.001

Notes:

Categorical parameters are described by absolute (relative) frequency. Differences are tested by Fisher’s exact test. Continuous parameters are described by mean (SD). Differences are tested by Kruskal–Wallis test. Significant differences are indicated in bold.

Abbreviations: 6-MWT, 6-minute walking test; ABG, arterial blood gas; BMI, body mass index; CAT, COPD Assessment Test; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; mMRC, modified Medical Research Council dyspnea scale; pred, predicted value; TLco, transfer factor for carbon monoxide.